[Clinical pharmacology and immunotherapy, 4th edition of the congress of pharmacology of anticancer drugs]

Bull Cancer. 2017 Sep;104(9):807-811. doi: 10.1016/j.bulcan.2017.06.005. Epub 2017 Aug 4.
[Article in French]
No abstract available

Keywords: Immune checkpoints; Immunothérapie; Nivolumab; Oncologie; Oncology; PD-1; Pharmacologie; Pharmacology.

Publication types

  • Congress

MeSH terms

  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers
  • Gastrointestinal Microbiome / immunology
  • Humans
  • Immune System
  • Immunotherapy*
  • Neoplasms / drug therapy*
  • Nivolumab
  • Pharmacology, Clinical*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Biomarkers
  • Programmed Cell Death 1 Receptor
  • Nivolumab